Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells

International Journal of Oncology

Volumn 31, Issue 2, 2007, Pages 323-331

  Ogawa, Mutsumi ^a   Nakai, Seiji ^a   Deguchi, Akihiro ^a   Nonomura, Takako ^a   Masaki, Tsutomu ^a   Uchida, Naohito ^a   Yoshiji, Hitoshi ^b   Kuriyama, Shigeki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Antitumor effect; Apoptosis; Caspase; Colorectal cancer; Vitamin K

Indexed keywords

4 AMINO 2 METHYL 1 NAPHTHOL; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FARNOQUINONE; FLUORESCEIN ISOTHIOCYANATE; MENADIONE; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; COLORECTAL TUMOR; DOSE RESPONSE; HUMAN; MOUSE; NEOPLASM; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROPIDIUM; VITAMIN K 2; VITAMIN K 3;

EID: 35148874285     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.31.2.323     Document Type: Article

References (51)

1. Parkin DM: International variation. Oncogene 23: 6329-6340, 2004.
2. Parkin D, Bray F and Devesa S: Cancer burden in the year 2000. The global picture. Eur J Cancer 37: 64-66, 2001.
3. Nicholson FB, Barro JL, Atkin W, Lilford R, Patnick J, Williams CB, Pignone M, Steele R and Kamm MA: Review article: population screening for colorectal cancer. Aliment Pharmacol Ther 22: 1069-1077, 2005. (Pubitemid 41779514)
4. Russo A, Corsale S, Cammareri P, Agnese V, Cascio S, Di Fede G, Macaluso M and Bazan V: Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy. J Cell Physiol 204: 742-749, 2005.
5. Esmon CT, Suttie JW and Jackson CM: The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin. J Biol Chem 250: 4095-4099, 1975.
6. Tuan RS: Vitamin K-dependent gamma-glutamyl carboxylase activity in the chick embryonic chorioallantoic membrane. J Biol Chem 254: 1356-1364, 1979.
7. Mijares ME, Nagy E, Guerrero B and Arocha-Pinango CL: Vitamin K: biochemistry, function, and deficiency. Review. Invest Clin 39: 213-229, 1998.
8. Li ZQ, He FY, Stehle CJ, Wang Z, Kar S, Finn FM and Carr BI: Vitamin K uptake in hepatocytes and hepatoma cells. Life Sci 70: 2085-2100, 2002. (Pubitemid 34219460)
9. Merrifield LS and Yang HY: Vitamin K5 as a fungistatic agent. Appl Microbiol 13: 660-662, 2002.
10. Maegawa H, Kobayashi M, Watanabe N, Ishibashi O, Takata Y and Shigeta Y: Inhibition of down regulation by chloroquine in cultured lymphocytes (RPMI-1788 line). Diabetes Res Clin Pract 1: 145-153, 1985. (Pubitemid 17036322)
11. Taketomi S, Fujita T and Yokono K: Insulin receptor and postbinding defects in KK mouse adipocytes and improvement by ciglitazone. Diabetes Res Clin Pract 5: 125-134, 1998.
12. Wang Z, Wang M, Finn F and Carr BI: The growth inhibitory effects of vitamins K and their actions on gene expression. Hepatology 22: 876-882, 1995.
13. Markovits J, Wang Z, Carr BI, Sun TP, Mintz P, Le Bret M, Wu CW and Wu FY: Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells. Life Sci 72: 2769-2784, 2003.
14. Chen C, Liu YZ, Shia KS and Tseng HY: Synthesis and anticancer evaluation of vitamin K3 analogues. Bioorg Med Chem Lett 12: 2729-2732, 2002. (Pubitemid 35251876)
15. Nutter LM, Cheng AL, Hung HL, Hsieh RK, Ngo EO and Liu TW: Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochem Pharmacol 41: 1283-1292, 1991.
16. Kim HJ, Mun JY, Chun YJ, Choi KH, Ham SW and Kim MY: Effects of a naphthoquinone analog on tumor growth and apoptosis induction. Arch Pharm Res 26: 405-410, 2003.
17. Lamson DW and Plaza SM: The anticancer effects of vitamin K. Altern Med Rev 8: 303-318, 2003.
18. Sakai I, Hashimoto S, Yoda M, Hida T, Ohsawa S, Nakajo S and Nakaya K: Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines. Biochem Biophys Res Commun 205: 1305-1310, 1994.
19. Bouzahzah B, Nishikawa Y, Simon D and Carr BI: Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: inhibitory actions of vitamin K. J Cell Physiol 165: 459-467, 1995. (Pubitemid 26004303)
20. Yaguchi M, Miyazawa K, Katagiri T, Nishimaki J, Kizaki M, Tohyama K and Toyama K: Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid. Leukemia 11: 779-787, 1997.
21. Yaguchi M, Miyazawa K, Otawa M, Katagiri T, Nishimaki J, Uchida Y, Iwase O, Gotoh A, Kawanishi Y and Toyama K: Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody. Leukemia 12: 1392-1397, 1998.
22. Nishimaki J, Miyazawa K, Yaguchi M, Katagiri T, Kawanishi Y, Toyama K, Ohyashiki K, Hashimoto S, Nakaya K and Takiguchi T: Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation. Leukemia 13: 1399-1405, 1999.
23. Sun LK, Yoshii Y and Miyagi K: Cytotoxic effect through fas/Apo-1 expression due to vitamin K in human glioma cells. J Neurooncol 47: 31-38, 2000. (Pubitemid 30458403)
24. Chlebowski RT, Akman SA and Block JB: Vitamin K in the treatment of cancer. Cancer Treat Rev 12: 49-63, 1985.
25. Furie B and Furie BC: Molecular basis of vitamin K-dependent gamma-carboxylation. Blood 75: 1753-1762, 1990. (Pubitemid 20161485)
26. Wu FY, Liao WC and Chang HM: Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci 52: 1797-1804, 1993.
27. Nishikawa Y, Carr BI, Wang M, Kar S, Finn F, Dowd P, Zheng ZB, Kerns J and Naganathan S: Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem 270: 28304-28310, 1995.
28. Verrax L, Cadrobbi J, Delvaux M, Jamison JM, Gilloteaux J, Summers JL, Taper HS and Buc Calderon P: The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem 38: 451-457, 2003.
29. Byczkowski JZ and Gessner T: Inhibition of the redox cycling of vitamin K3 (menadione) in mouse liver microsomes. Int J Biochem 20: 1073-1079, 1998.
30. Chlebowski RT, Dietrich M, Akman S and Block JB: Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. Cancer Treat Rep 69: 527-532, 1985. (Pubitemid 15031402)
31. Otsuka M, Kato N, Shao RX, Hoshia Y, Ijichi H, Koike Y, Taniguchi H, Moriyama M, Shiratori Y, Kawabe T and Omata M: Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology 40: 243-251, 2004.
32. Tsuruo T, Yamori T, Naganuma K, Tsukagoshi S and Sakurai Y: Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res 43: 5437-5442, 1983. (Pubitemid 14230162)
33. Kuriyama S, Nakatani T, Masui K, Sakamoto T, Tominaga K, Yoshikawa M, Fukui H, Ikenaka K and Tsujii T: Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology 22: 1838-1846, 1995.
34. Nakajima H, Park HL and Henkart PA: Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J Exp Med 181: 1037-1046, 1995.
35. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW and Thornberry NA: Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 273: 32608-32613, 1998. (Pubitemid 28557641)
36. Yeatman TJ and Chambers AF: Osteopontin and colon cancer progression. Clin Exp Metastasis 20: 85-90, 2003.
37. D'Odorico A, Sturniolo GC, Bilton RF, Morris AI, Gilmore IT and Naccarato R: Quinone-induced DNA single strand breaks in a human colon carcinoma cell line. Carcinogenesis 18: 43-46, 1997. (Pubitemid 28134615)
38. Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, Koike K, Takaki A and Shiratori Y: Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 280: 6409-6415, 2005.
39. Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S and Nishiguchi S: Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA 292: 358-361, 2004.
40. Mizuta T, Ozaki I, Eguchi Y, Yasutake T, Kawazoe S, Fujimoto K and Yamamoto K: The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study. Cancer 106: 867-872, 2006.
41. Hitomi M, Yokoyama F, Kita Y, Nonomura T, Masaki T, Yoshiji H, Inoue H, Kinekawa F, Kurokohchi K, Uchida N, Watanabe S and Kuriyama S: Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int J Oncol 26: 713-720, 2005.
42. Hitomi M, Nonomura T, Yokoyama F, Yoshiji H, Ogawa M, Nakai S, Deguchi A, Masaki T, Inoue H, Kimura Y, Kurokohchi K, Uchida N and Kuriyama S: In vitro and in vivo antitumor effects of vitamins K5 on hepatocellular carcinoma. Int J Oncol 26: 1337-1344, 2005.
43. Kuriyama S, Hitomi M, Yoshiji H, Nonomura T, Tsujimoto T, Mitoro A, Akahane T, Ogawa M, Nakai S, Deguchi A, Masaki T and Uchida N: Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Int J Oncol 27: 505-511, 2005.
44. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
45. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
46. Funato K, Miyazawa K, Yaguchi M, Gotoh A and Ohyashiki K: Combination of 22-oxa-1,25-dihydroxyvitamin D3, a vitamin D3 derivative, with vitamin K2 (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells. Leukemia 16: 1519-1527, 2002.
47. von Gruenigen VE, Jamison JM, Gilloteaux J, Lorimer HE, Summers M, Pollard RR, Gwin CA and Summers JL: The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma. Anticancer Res 23: 3279-3287, 2003.
48. Liao WC, Wu FY and Wu CW: Binary/ternary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CG1 cells. Int J Oncol 17: 323-328, 2000.
49. Gold J: In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals. Cancer Treat Rep 70: 1433-1435, 1986.
50. Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Masaki T and Fukui H: Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, peridopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression. J Hepatol 42: 687-693, 2005.
51. Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Akahane T, Asada K, Tsujimoto T, Uemura M and Fukui H: Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities. Oncol Rep 15: 155-159, 2006.